An Online Intervention Promoting HPV Vaccination Among Chinese MSM
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04815837|
Recruitment Status : Recruiting
First Posted : March 25, 2021
Last Update Posted : March 25, 2021
|Condition or disease||Intervention/treatment||Phase|
|Vaccine Refusal||Behavioral: Intervention||Not Applicable|
The primary objective of this study is to investigate prevalence of uptake of Human Papillomavirus (HPV) vaccination after exposure to health promotion among men who have sex with men in Hong Kong within a 12-month project period.
Inclusion criteria are Hong Kong Chinese speaking males aged 18-45 years old and self-reported having had oral or anal intercourse with at least one man in the last six months. Those who have ever received HPV vaccination are excluded.
Participants are recruited through outreaching in gay venues, online advertisement and referral made by peers and non-governmental organization. With verbal informed consent, participants completed a baseline survey through telephone. They are then exposed to online interventions including: 1) watching an online video, 2) receiving a discount coupon to receive HPV vaccination at collaborative private clinics, 3) visiting the project webpage, and 4) receiving follow-up reminders 1, 2, 4, 6, and 8 months after the baseline survey.
All participants are followed up by telephone 12 months after the baseline survey to access the primary outcome.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||350 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||An Evidence-based Knowledge Transfer Program Promoting Human Papillomavirus (HPV) Vaccination Among Men Who Have Sex With Men in Hong Kong|
|Actual Study Start Date :||September 1, 2019|
|Estimated Primary Completion Date :||June 2021|
|Estimated Study Completion Date :||June 2021|
Participants received the following interventions:
- Taking up at least one dose of Human Papillomavirus (HPV) vaccination in the past year [ Time Frame: 12 months ]Participants report how many doses of HPV vaccines they have taken up in the past year.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04815837
|Contact: Zixin Wang, PhD||+852 email@example.com|
|Principal Investigator:||Zixin Wang, PhD||Chinese University of Hong Kong|